KATRD
LOGIN
- KATRD 2021 International Conference
-
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program in Detail
한국어 진행 강의입니다.
|
Opening Ceremony |
08:20-08:30 Crystal Ballroom 1 |
||
|---|---|---|---|
| 08:20-08:30 |
Opening Address
O Jung Kwon (President, KATRD)
|
||
|
Welcome Address
Jae Jeong Shim (KATRD Chairman of the Board of Trustees, Korea University, Korea)
|
|||
|
Plenary Session 1 |
08:30-10:00 Crystal Ballroom 1 |
||
| Chairs |
Jae Jeong Shim (KATRD Chairman of the Board of Trustees, Korea University, Korea) Hojoong Kim (Sungkyunkwan University, Korea) |
||
| 08:30-09:00 | PS 1-1 |
Approach and Management of Elderly Lung Cancer Patients in Super-aged Society
Yoichi Nakanishi (APSR President, Kitakyushu City Hospital Organization, Japan)
|
|
| 09:00-09:30 | PS 1-2 |
The Importance of Effective Registries in Pulmonary Diseases and How to Optimize Their Output
Joanna Chorostowska-Wynimko (ERS Secretary General, European Respiratory Society, Poland)
|
|
| 09:30-10:00 | PS 1-3 |
Update of Combined Pulmonary Fibrosis and Emphysema (CPFE)
Vincent Cottin (University of Lyon, France)
|
|
|
Break |
10:00-10:30 |
||
|
[Symposium 01] Airway Disease 1 - Controversies and Perspectives in Airway Diseases |
10:30-12:00 Crystal Ballroom 1 |
||
| Chair | Yeon-Mok Oh (University of Ulsan, Korea) | ||
| 10:30-11:00 | SY 1-1 |
Controversies and Opportunities in Severe Asthma
Marc Humbert (ERS President, Paris-Saclay University, France)
|
|
| 11:00-11:30 | SY 1-2 |
Current Controversies and Future Perspectives in COPD
Bartolome Celli (Harvard Medical School, USA)
|
|
| 11:30-12:00 | SY 1-3 |
The Importance of Real-life Research in Respiratory Medicine
Nicolas Roche (University of Paris, France)
|
|
|
[Symposium 04] Interstitial Lung Disease 1 - Wide Spectrum of Fibrotic Lung Diseases in Real World |
10:30-12:00 Crystal Ballroom 2 |
||
| Chair | Yong Hyun Kim (The Catholic University of Korea, Korea) | ||
| 10:30-11:00 | SY 4-1 |
Wide Spectrum of Fibrotic Lung Disease in Real World
Vincent Cottin (University of Lyon, France)
|
|
| 11:00-11:30 | SY 4-2 |
Diagnosis and Management of Interstitial Lung Disease in Rheumatoid Arthritis
Vu Van Giap (Viet Nam Respiratory Society (VNRS), Vietnam)
|
|
| 11:30-12:00 | SY 4-3 |
SSc-ILD: Current Evidences and Application
Jong Sun Park (Seoul National University, Korea)
|
|
|
[Symposium 07] Lung Cancer 1 - New Applicable Biomarkers in Lung Cancer |
10:30-12:00 Crystal Ballroom 3 |
||
| Chair | Sei Hoon Yang (Wonkwang University, Korea) | ||
| 10:30-11:00 | SY 7-1 |
Navigating the Evolving NSCLC 1L Treatment Landscape with a Focus on Nivolumab + Ipilimumab
Satoshi Ikeda (Kanagawa Cardiovascular and Respiratory Center, Japan)
|
|
| 11:00-11:30 | SY 7-2 |
Current Achievement and Future Perspective of Genome Profiling by Liquid Biopsy
Naoko Aragane (Saga University Hospital, Japan)
|
|
| 11:30-12:00 | SY 7-3 |
Imaging Biomarkers in Lung Cancer
Jin Mo Goo (Seoul National University, Korea)
|
|
|
[Symposium 19] Management of Airway Diseases in Asia |
10:30-12:00 Emerald Room |
||
| Chair | Ho Joo Yoon (Hanyang University, Korea) | ||
| 10:30-11:00 | SY 19-1 |
Early Detection and Management of COPD
Ching-Hsiung Lin (Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), Taiwan)
|
|
| 11:00-11:30 | SY 19-2 |
Philippine COPD Pathway Project
Bernice Ong-dela Cruz (Philippine College of Chest Physicians (PCCP), Philippines)
|
|
| 11:30-12:00 | SY 19-3 |
Diagnosis and Management of Benign Central Airway Stenosis: Experience from Vietnam
Ngo Quy Chau (VNRS President, Viet Nam Respiratory Society (VNRS), Vietnam)
|
|
|
[Luncheon Symposium 01] Airway Disease 
|
12:00-12:30 Crystal Ballroom 1 |
||
| Chair | Yun-Seong Kim (Pusan National University, Korea) | ||
| 12:00-12:30 | LS 1 |
Which Types of Asthma Patients Would Benefit from Omalizumab?
Marc Humbert (ERS President, Paris-Saclay University, France)
|
|
|
[Luncheon Symposium 02] Interstitial Lung Disease 
|
12:00-12:30 Crystal Ballroom 2 |
||
| Chair | Sung Woo Park (Soon Chun Hyang University, Korea) | ||
| 12:00-12:30 | LS 2 |
Antifibrotic Therapy in Japan: Long Term Treatment Experience of Pirfenidone
Hirofumi Chiba (Sapporo Medical University, Japan)
|
|
|
[Luncheon Symposium 03] Lung Cancer 
|
12:00-12:30 Crystal Ballroom 3 |
||
| Chair | Yoon Soo Chang (Yonsei University, Korea) | ||
| 12:00-12:30 | LS 3 |
Transform Treatment Strategy for EGFRm NSCLC Patients from Early to Advanced Stage
In-Jae Oh (Chonnam National University, Korea)
|
|
|
Break |
12:30-13:30 |
||
|
[Symposium 02] Airway Disease 2 - Current and Future of Using Biomarkers in the Management of Airway Diseases |
13:30-15:00 Crystal Ballroom 1 |
||
| Chair | Yong Chul Lee (Jeonbuk National University, Korea) | ||
| 13:30-14:00 | SY 2-1 |
Blood and Sputum Eosinophil as a Biomarker of COPD
Dave Singh (University of Manchester, UK)
|
|
| 14:00-14:30 | SY 2-2 |
Biomarkers and Biologics for Severe Asthma
Klaus F. Rabe (German Center for Lung Research (DZL), Germany)
|
|
| 14:30-15:00 | SY 2-3 |
Multi-Omics Based Precision Medicine in Asthma
Tae-Bum Kim (University of Ulsan, Korea)
|
|
|
[Symposium 05] Interstitial Lung Disease 2 - Update of Rare and Orphan Lung Diseases |
13:30-15:00 Crystal Ballroom 2 |
||
| Chair | Moo Suk Park (Yonsei University, Korea) | ||
| 13:30-14:00 | SY 5-1 |
Pulmonary Alveolar Proteinosis: No Longer Orphan in New Era?
Yoshikazu Inoue (National Hospital Organization Kinki-Chuo Chest Medical Center, Japan)
|
|
| 14:00-14:30 | SY 5-2 |
Lymphangioleiomatosis
Yangjin Jegal (Ulsan University, Korea)
|
|
| 14:30-15:00 | SY 5-3 |
Pleuroparenchymal Fibroelastosis (PPFE)
Takafumi Suda (Hamamatsu University School of Medicine, Japan)
|
|
|
[Symposium 08] Lung Cancer 2 - Additional Treatment: Worthwhile and When |
13:30-15:00 Crystal Ballroom 3 |
||
| Chair | Kye Young Lee (Konkuk University, Korea) | ||
| 13:30-14:00 | SY 8-1 |
Adjuvant Chemotherapy of Completely Resected Stage 1 Non-Small Cell Lung Cancer
Shin Yup Lee (Kyungpook National University, Korea)
|
|
| 14:00-14:30 | SY 8-2 |
Abscopal Effect of Radiotherapy Combined with Immune Checkpoint Inhibitors
Chang Dong Yeo (The Catholic University of Korea, Korea)
|
|
| 14:30-15:00 | SY 8-3 |
Salvage Surgery for Non-Small Cell Lung Cancer After Tyrosine Kinase Inhibitor Treatment
Chaeuk Chung (Chungnam National University, Korea)
|
|
|
Break |
15:00-15:30 |
||
|
[Symposium 03] Environmental Lung Disease - Hot Topics in Environmental Lung Diseases in 2021 |
15:30-17:00 Crystal Ballroom 1 |
||
| Chair | Sung Hwan Jeong (Gachon University, Korea) | ||
| 15:30-16:00 | SY 3-1 |
Humidifier Disinfectant (HD) and Bronchial Asthma
Hyoung-Kyu Yoon (The Catholic University of Korea, Korea)
|
|
| 16:00-16:30 | SY 3-2 |
Climate Change and Related Medical Problems
Jun-Pyo Myong (The Catholic University of Korea, Korea)
|
|
| 16:30-17:00 | SY 3-3 |
Changes in Air Pollution during the COVID-19 Pandemic and Related Health Effects
Sun-Young Kim (National Cancer Center, Korea)
|
|
|
[Symposium 06] Tuberculosis - Beyond the Current Treatment of Tuberculosis |
15:30-17:00 Crystal Ballroom 2 |
||
| Chair | Jae Chol Choi (Chung-Ang University, Korea) | ||
| 15:30-16:00 | SY 6-1 |
Personalized Therapy for TB
Jan Heyckendorf (Research Center Borstel, Germany)
|
|
| 16:00-16:30 | SY 6-2 |
Host-Directed Therapy for Tuberculosis
Nakwon Kwak (Seoul National University, Korea)
|
|
| 16:30-17:00 | SY 6-3 |
TB Co-infection among COVID Confirmed Patients – The Philippine Experience
Jubert Benedicto (Philippine College of Chest Physicians (PCCP), Philippines)
|
|
|
[Symposium 09] Lung Cancer 3 - Beyond Standard Treatment |
15:30-17:00 Crystal Ballroom 3 |
||
| Chair | Seung Joon Kim (The Catholic University of Korea, Korea) | ||
| 15:30-16:00 | SY 9-1 |
The Emerging Therapeutic Landscape of ALK TKIs in Advanced NSCLC
Herbert Loong (The Chinese University of Hong Kong, Hong Kong)
|
|
| 16:00-16:30 | SY 9-2 |
Immune Checkpoint Inhibitors in NSCLC with Driver Mutations
Seung Yong Park (Jeonbuk National University, Korea)
|
|
| 16:30-17:00 | SY 9-3 |
Management of Brain Metastasis Considering Molecular Profiling
James Chih-Hsin Yang (National Taiwan University Cancer Center, Taiwan)
|
|
|
Break |
17:00-17:15 |
||
|
[Satellite Symposium 1] Airway Disease 
|
17:15-18:15 Crystal Ballroom 1 |
||
| Chair | Joohun Park (Ajou University, Korea) | ||
| 17:15-17:45 | SS 1-1 |
Why Wouldn’t We Intervene Earlier in Patients at Risk of Exacerbation?
Alberto Papi (University of Ferrara, Italy)
|
|
| 17:45-18:15 | SS 1-2 |
Should You Initiate Treatment with One or Two Bronchodilators?
Claus F. Vogelmeier (University of Marburg, Germany)
|
|
|
[Satellite Symposium 2] Airway Disease
|
17:15-17:45 Crystal Ballroom 2 |
||
| Chair | Myung Jae Park (Kyung Hee University, Korea) | ||
| 17:15-17:45 | SS 2 |
Reconsidering the Potential of Inhaled Therapies in Asthma
Nicolas Roche (University of Paris, France)
|
|
|
[Satellite Symposium 3] Interstitial Lung Disease / Airway Disease 
|
17:15-18:15 Crystal Ballroom 3 |
||
| Chair | Man Pyo Chung (Sungkyunkwan University, Korea) | ||
| 17:15-17:45 | SS 3-1 |
Exploring Optimal Treatment Options for Progressive Fibrosing ILDs : How to Treat?
Jin Woo Song (University of Ulsan, Korea)
|
|
| 17:45-18:15 | SS 3-2 |
What Do COPD Real World Studies Tell Us about LAMA/LABA Initiation in Maintenance Therapy?
Jennifer Quint (Imperial College London, UK)
|
|